BridgeMD
Compares treatment options for Burns Degree Second
Official title Comparing How Burn Wounds and Scars Heal in Children Using Chitosan and Silver Dressings
ClinicalTrials.gov ID: NCT06987981
What this study is testing
- What it's testing
- Burns are among the most common types of trauma worldwide, ranking fourth after traffic accidents, falls, and violence, and account for an estimated 265,000 deaths annually (WHO). Most burn injuries result from heat exposure, though other causes include friction, chemicals, and electricity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 17
You may be able to join if
- Age between 6 months and 17 years old
- Having a first or second-degree superficial burn that does not require excision and grafting
- Patients with a burn of less than 20% of the total body surface area (TBSA)
- Admission within 72 hours of burn injury
- First line of therapy is Burnshield® Dressing for the first 48 hours
You likely can't join if
- Causes other than contact burn, flame or scald injuries (i.e., electrical, chemical or frostbite)
- Diabetes mellitus
- Significant cardiac, pulmonary, or renal insufficiency
- Severe hematologic disease, malignancy, hypo-immunity
- Wounds noted to be contaminated or infected
- Systemic inflammatory response syndrome (SIRS) or sepsis
See the full eligibility criteria
- Age between 6 months and 17 years old
- Having a first or second-degree superficial burn that does not require excision and grafting
- Patients with a burn of less than 20% of the total body surface area (TBSA)
- Admission within 72 hours of burn injury
- First line of therapy is Burnshield® Dressing for the first 48 hours
- Clean non-infected wound as diagnosed by the attending physician
- Informed consent of the patient or caregiver
- Causes other than contact burn, flame or scald injuries (i.e., electrical, chemical or frostbite)
- Diabetes mellitus
- Significant cardiac, pulmonary, or renal insufficiency
- Severe hematologic disease, malignancy, hypo-immunity
- Wounds noted to be contaminated or infected
- Systemic inflammatory response syndrome (SIRS) or sepsis
- Moderate or severe respiratory tract or lungs burn injuries
- Previous treatment efforts such as previous debridement, silver sulfadiazine ointment or other topical agents (e.g.: oil, toothpaste, betadine, rivano)
- Being pregnant or breastfeeding
- Known sensitivity or allergy to one of the dressings or its components.
The study team makes the final eligibility decision.
Where it's taking place
- Novo Mesto, Slovenia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Novo Mesto, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.